Your browser doesn't support javascript.
loading
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.
Mitnick, Carole D; White, Richard A; Lu, Chunling; Rodriguez, Carly A; Bayona, Jaime; Becerra, Mercedes C; Burgos, Marcos; Centis, Rosella; Cohen, Theodore; Cox, Helen; D'Ambrosio, Lia; Danilovitz, Manfred; Falzon, Dennis; Gelmanova, Irina Y; Gler, Maria T; Grinsdale, Jennifer A; Holtz, Timothy H; Keshavjee, Salmaan; Leimane, Vaira; Menzies, Dick; Migliori, Giovanni Battista; Milstein, Meredith B; Mishustin, Sergey P; Pagano, Marcello; Quelapio, Maria I; Shean, Karen; Shin, Sonya S; Tolman, Arielle W; van der Walt, Martha L; Van Deun, Armand; Viiklepp, Piret.
Afiliação
  • Mitnick CD; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Partners in Health, Boston, MA, USA carole_mitnick@hms.harvard.edu.
  • White RA; Dept of Infectious Disease Epidemiology, Norwegian Institute of Public Health, Oslo, Norway Dept of Health Statistics, Norwegian Institute of Public Health, Oslo, Norway.
  • Lu C; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA, USA.
  • Rodriguez CA; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
  • Bayona J; Socios en Salud Sucursal, Lima, Peru.
  • Becerra MC; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Partners in Health, Boston, MA, USA Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA, USA.
  • Burgos M; Dept of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA.
  • Centis R; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.
  • Cohen T; Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
  • Cox H; Médecins Sans Frontières, Cape Town, South Africa.
  • D'Ambrosio L; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland.
  • Danilovitz M; Tartu University Hospital, Lung Clinic, Tartu, Estonia.
  • Falzon D; Global TB Programme, World Health Organization, Geneva, Switzerland.
  • Gelmanova IY; Partners in Health Russia, Moscow, Russia.
  • Gler MT; Makati Medical Center, Manila, Philippines.
  • Grinsdale JA; Tuberculosis Control, San Francisco Department of Public Health, San Francisco, CA, USA.
  • Holtz TH; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Keshavjee S; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Partners in Health, Boston, MA, USA Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA, USA.
  • Leimane V; State Agency for Tuberculosis and Lung Diseases (TPSVA), Riga, Latvia.
  • Menzies D; Montreal Chest Institute, McGill University, Montreal, QC, Canada.
  • Migliori GB; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.
  • Milstein MB; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA.
  • Mishustin SP; Tomsk TB and Pulmonary Medical Center, Tomsk Oblast, Russia.
  • Pagano M; Dept of Biostatistics, Harvard School of Public Health, Boston, MA, USA.
  • Quelapio MI; Tropical Disease Foundation, Philippine Institute of Tuberculosis, Makati City, Philippines.
  • Shean K; Lung Infection and Immunity Unit, Division of Pulmonology and UCT Lung Institute, Dept of Medicine, University of Cape Town, Cape Town, South Africa.
  • Shin SS; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA Partners in Health, Boston, MA, USA Brigham and Women's Hospital, Division of Global Health Equity, Boston, MA, USA Socios en Salud Sucursal, Lima, Peru.
  • Tolman AW; Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
  • van der Walt ML; South African Medical Research Council, Tuberculosis Research Platform, Pretoria, South Africa.
  • Van Deun A; Institute of Tropical Medicine, Antwerp, Belgium.
  • Viiklepp P; National Institute for Heath Development, Tallinn, Estonia.
Eur Respir J ; 48(4): 1160-1170, 2016 10.
Article em En | MEDLINE | ID: mdl-27587552
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Antituberculosos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Systematic_reviews Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Antituberculosos Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Systematic_reviews Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Respir J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos